The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Sitagliptin/Metformin Hydrochloride Accord



Accord Healthcare S.L.U.EU/1/22/1661/017-032

Main Information

Trade NameSitagliptin/Metformin Hydrochloride Accord
Active SubstancesSitagliptin Hydrochloride Monohydrate
Metformin Hydrochloride
Dosage FormFilm-coated tablet
Licence HolderAccord Healthcare S.L.U.
Licence NumberEU/1/22/1661/017-032

Group Information

ATC CodeA10BD07 metformin and sitagliptin

Status

License statusAuthorised
Licence Issued22/07/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0070-122-003
Interchangeable List DocumentPDF of Interchangeable List
« Back